SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-030267
Filing Date
2024-03-04
Accepted
2024-03-04 09:00:21
Documents
24
Period of Report
2024-02-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm247820d1_8k.htm   iXBRL 8-K 39948
2 EXHIBIT 1.1 tm247820d1_ex1-1.htm EX-1.1 249972
3 EXHIBIT 4.1 tm247820d1_ex4-1.htm EX-4.1 64638
4 EXHIBIT 5.1 tm247820d1_ex5-1.htm EX-5.1 12025
5 EXHIBIT 5.2 tm247820d1_ex5-2.htm EX-5.2 13584
6 EXHIBIT 99.1 tm247820d1_ex99-1.htm EX-99.1 11384
7 EXHIBIT 99.2 tm247820d1_ex99-2.htm EX-99.2 11030
11 GRAPHIC tm247820d1_ex99-2img01.jpg GRAPHIC 4597
12 GRAPHIC tm247820d1_ex99-2img02.jpg GRAPHIC 4574
13 GRAPHIC tm247820d_ex5-1img01.jpg GRAPHIC 2822
14 GRAPHIC tm247820d_ex5-2img002.jpg GRAPHIC 3154
  Complete submission text file 0001104659-24-030267.txt   704486

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA mist-20240228.xsd EX-101.SCH 3036
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mist-20240228_lab.xml EX-101.LAB 34240
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mist-20240228_pre.xml EX-101.PRE 22373
26 EXTRACTED XBRL INSTANCE DOCUMENT tm247820d1_8k_htm.xml XML 3847
Mailing Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6
Business Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38899 | Film No.: 24713000
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)